Literature DB >> 16376610

Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects.

Eloisa Arbustini1, Michele Pasotti, Andrea Pilotto, Carlo Pellegrini, Maurizia Grasso, Stefano Previtali, Alessandra Repetto, Ornella Bellini, Gaetano Azan, Manuela Scaffino, Carlo Campana, Giovanni Piccolo, Mario Viganò, Luigi Tavazzi.   

Abstract

BACKGROUND: Primary desminopathies are caused by desmin gene [DES (MIM*125660)] mutations. The clinical spectrum includes pure myopathies, cardiomuscular diseases and cardiomyopathies. Patients with restrictive cardiomyopathy (RCM) plus atrioventricular block (AVB) due to DES defects are frequently unrecognized unless desmin accumulation is specifically investigated in endomyocardial biopsy (EMB) by ultrastructural study. AIMS: To describe a cardiological phenotype characterized by RCM plus AVB due to desmin accumulation caused by DES defects. METHODS AND
RESULTS: Desmin accumulation was diagnosed by means of ultrastructural and immunocytochemical studies of EMB in four unrelated probands with RCM and AVB. Candidate genes [DES and alphaB-crystallin (CRYAB)] were screened using sequence analysis. Four DES gene mutations were identified: three new (R16C, T453I and a 10 bp deletion at the exon-intron boundary of exon 3 disrupting the donor splice site) and one known (R406W). The disease was autosomal dominant in two families, recessive in one and associated with a de novo mutation in one. The mutations cosegregated with phenotype in all patients. CRYAB gene screening was negative.
CONCLUSIONS: A cardiac phenotype characterized by RCM and AVB caused by desmin accumulation is associated with DES mutations. Although the mutations affected different domains, the cardiac phenotype was identical.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376610     DOI: 10.1016/j.ejheart.2005.11.003

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  47 in total

1.  Right ventricular protein expression profile in end-stage heart failure.

Authors:  Yan Ru Su; Manuel Chiusa; Evan Brittain; Anna R Hemnes; Tarek S Absi; Chee Chew Lim; Thomas G Di Salvo
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 2.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

3.  Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

4.  Disease mutations in the "head" domain of the extra-sarcomeric protein desmin distinctly alter its assembly and network-forming properties.

Authors:  Sarika Sharma; Norbert Mücke; Hugo A Katus; Harald Herrmann; Harald Bär
Journal:  J Mol Med (Berl)       Date:  2009-09-08       Impact factor: 4.599

Review 5.  Precision medicine approach to genetic cardiomyopathy.

Authors:  K Filonenko; H A Katus; B Meder
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

6.  A novel desmin mutation causing severe left ventricular arrhythmogenic cardiomyopathy/dysplasia.

Authors:  George Bazoukis; Konstantinos P Letsas; Yunlong Xia; Gary Tse; Ka Hou Christien Li
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

7.  The desmin coil 1B mutation K190A impairs nebulin Z-disc assembly and destabilizes actin thin filaments.

Authors:  Gloria M Conover; Carol C Gregorio
Journal:  J Cell Sci       Date:  2011-10-07       Impact factor: 5.285

Review 8.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

9.  Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain.

Authors:  Paul Maddison; Maxwell S Damian; Caroline Sewry; Catherine McGorrian; John B Winer; Zagaa Odgerel; Alexey Shatunov; Hee Suk Lee; Lev G Goldfarb
Journal:  Eur Neurol       Date:  2012-10-05       Impact factor: 1.710

10.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.